Indication

Sulfadiazine toxicity

Sulfadiazine toxicity refers to the spectrum of adverse drug reactions, acute overdose manifestations, or organ toxicities resulting from systemic exposure to the sulfonamide antibiotic sulfadiazine. Read more about Sulfadiazine toxicity

45 drugs 36 manufacturers

Advertisement

Drugs that treat it

Common Sulfadiazine toxicity therapies.

Showing 28–36 of 45 drugs

LEUCOVORIN CALCIUM

FOLIC ACID·FOLIC ACID DEFICIENT MEGALOBLASTIC ANEMIA·+7
MYLAN INSTITUTI

LEUCOVORIN CALCIUM

FOLIC ACID·FOLIC ACID DEFICIENT MEGALOBLASTIC ANEMIA·+7
SLATE RUN PHARM
Filter & compare in the drug finder →Opens the drug finder with Sulfadiazine toxicity preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Sulfadiazine toxicity.

Sulfadiazine toxicity refers to the spectrum of adverse drug reactions, acute overdose manifestations, or organ toxicities resulting from systemic exposure to the sulfonamide antibiotic sulfadiazine.

It predominantly impacts the renal, dermatologic, hematologic, and hepatic systems.

Defining clinical and pathophysiologic features include crystalluria leading to obstructive acute kidney injury and nephrolithiasis due to the precipitation of insoluble drug metabolites in acidic urine, idiosyncratic severe cutaneous adverse reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis, bone marrow suppression manifesting as leukopenia, agranulocytosis, or thrombocytopenia, and kernicterus in neonates secondary to displacement of bilirubin from albumin binding sites.

Personalize your experience

Follow Sulfadiazine toxicity and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it